Translational optoelectronic control of cardiac rhythm in atrial fibrillation

This project aims to develop a shock-free, optoelectronic method for controlling cardiac rhythm in atrial fibrillation using engineered 3D heart models and advanced monitoring systems.

Subsidie
€ 1.999.999
2023

Projectdetails

Introduction

It’s my conviction that, one day, we will enable the human heart to terminate its own rhythm disturbances and thereby restore its normal rhythm at any place and time. Such acute restoration of cardiac rhythm would not be based on traumatizing electric shocks, but on the generation of bioelectricity by the affected heart itself.

Project Goals

In order to explore this paradigm-changing approach for ambulatory shock-free control of cardiac rhythm, I will integrate the unique advances of:

  1. Genetic engineering
  2. Computer modelling
  3. Tissue engineering
  4. Micro-optoelectronics

To determine the advanced and translational potential of such optoelectronic heart rhythm control, the most prevalent cardiac arrhythmia will be targeted: atrial fibrillation (AF).

Methodology

To this purpose, we will first engineer human atrium-sized 3D models of AF from fully functional conditionally immortalized human atrial cardiomyocytes expressing light-gated ion channels.

To realize and explore optoelectronic rhythm control in these models, customized multi-electrode-LED arrays (MELAs) will be integrated to gain full control over bioelectricity generation by precisely tailored illumination. Such illumination will be accomplished by a modular interactive optoelectronic system allowing continuous, accurate, and real-time monitoring-based activation of specific LEDs in the MELAs.

Application and Insights

Insights from these studies will guide the application of this approach in pig models of AF to determine its feasibility, safety, and therapeutic implications. From design to interpretation, all these studies will be supported by advanced computer simulations to realize an iterative process of optimization for maximum project outcome.

Expected Outcomes

Establishing translational optoelectronic control of cardiac rhythm is expected to break new ground by revealing unique novel insights into AF mechanisms and management. This project could thus provide distinctively innovative therapeutic options while generating novel tools and concepts in medical research and care.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.999
Totale projectbegroting€ 1.999.999

Tijdlijn

Startdatum1-3-2023
Einddatum29-2-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • ACADEMISCH ZIEKENHUIS LEIDENpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC ADG

Unique non-invasive pace-mapping system to identify subjects at risk of arrhythmic sudden death

Develop a non-invasive mapping and pacing system to detect cardiac signals for predicting sudden cardiac death, improving early diagnosis and management of heart disease.

€ 2.488.400
ERC ADG

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

€ 2.500.000
ERC STG

Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatments

This project aims to understand cardiac electroporation mechanisms to develop methods for effective irreversible and reversible treatments for atrial fibrillation and ischemic heart disease.

€ 1.500.000
ERC STG

Unraveling pacemaker (dys)function using novel stem cell-derived human heart models

This project aims to enhance understanding of sinoatrial node function and its dysfunction in heart rhythm disorders using innovative in vitro models derived from human pluripotent stem cells.

€ 1.797.105